How to relieve constipation - the 10 reasons why constipation could be FATAL
CONSTIPATION is a common problem, but most people don't realise that it can be fatal. Here are 10 reasons why and how to treat constipation. (Source: Daily Express - Health)
Source: Daily Express - Health - October 14, 2021 Category: Consumer Health News Source Type: news

Constipation Med Boosts Cognitive Performance in Mental Illness Constipation Med Boosts Cognitive Performance in Mental Illness
For patients with mental illness, cognitive impairment appears to improve with the constipation drug prucalopride. The drug boosts recall as well as activity in related brain areas, new research shows.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - October 7, 2021 Category: Gastroenterology Tags: Psychiatry News Source Type: news

11 Things That Will Help You Poop Better (Seriously)
Relieve constipation or solve your other bathroom woes with these game-changing items. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - October 4, 2021 Category: Consumer Health News Source Type: news

The Best Products To Help You Poop Better
Relieve constipation or solve your other bathroom woes with these game-changing items. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - October 4, 2021 Category: Consumer Health News Source Type: news

Do you suffer with IBS? Your symptoms could be a sign of a more serious condition - expert
IRRITABLE bowel syndrome causes abdominal symptoms that include constipation, diarrhoea, or both. However, the condition does not damage a person's bowel like ulcerative colitis or Crohn's disease can. Symptoms can consist of flare ups that can cause excruciating pain and can make going about your daily life uncomfortable. For years, IBS has often been diagnosed before another, more serious condition. (Source: Daily Express - Health)
Source: Daily Express - Health - September 25, 2021 Category: Consumer Health News Source Type: news

The bias that blinds: why some people get dangerously different medical care
Medical research and practice have long assumed a narrow definition of the ‘default’ human, badly compromising the care of anyone outside that category. How can this be fixed?I met Chris in my first month at a small, hard-partying Catholic high school in north-eastern Wisconsin, where kids jammed cigarettes between the fingers of the school ’s lifesize Jesus statue and skipped mass to eat fries at the fast-food joint across the street. Chris and her circle perched somewhere adjacent to the school’s social hierarchy, and she surveyed the adolescent drama and absurdity with cool, heavy-lidded understa...
Source: Guardian Unlimited Science - September 21, 2021 Category: Science Authors: Jessica Nordell Tags: Science Health Doctors Medical research Hospitals Women & wellbeing GPs Race Gender Source Type: news

How Can I Relieve My Baby's Constipation Fast?
Title: How Can I Relieve My Baby's Constipation Fast?Category: Diseases and ConditionsCreated: 9/20/2021 12:00:00 AMLast Editorial Review: 9/20/2021 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - September 20, 2021 Category: Pediatrics Source Type: news

New Data on RYBREVANT ® (amivantamab-vmjw) in Combination with Lazertinib Show Early Activity in Patients with Non-Small Cell Lung Cancer Whose Disease Has Progressed After Both Osimertinib and Platinum-Based Chemotherapy
September 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced preliminary results from the Phase 1b CHRYSALIS-2 (NCT04077463) study evaluating RYBREVANT® (amivantamab-vmjw) in combination with lazertinib in the treatment of patients with non-small cell lung cancer (NSCLC) characterized by epidermal growth factor receptor (EGFR) exon 19 deletion or L858R mutations whose disease had progressed after treatment with osimertinib and platinum chemotherapy.[i] While previously reported results have demonstrated durable responses with RYBREVANT® in combination with...
Source: Johnson and Johnson - September 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

RYBREVANT ® (amivantamab-vmjw) Provides Higher Activity and Longer Duration of Response When Used in Combination with Lazertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer Who Have Failed Osimertinib
September 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced a new analysis from the CHRYSALIS (NCT02609776) study evaluating RYBREVANT® (amivantamab-vmjw) monotherapy and a combination regimen with lazertinib in advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations who progressed after osimertinib.[1] The analysis showed higher activity and longer duration of response (DOR) in patients treated with the combination therapy, demonstrating the potential benefit of targeting the extracellular (outer) and catal...
Source: Johnson and Johnson - September 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Presents Results from Phase 1b/2 NORSE Study in Patients with Metastatic or Locally Advanced Urothelial Carcinoma Treated with BALVERSA ® (erdafitinib) in Combination with Cetrelimab, a PD-1 Inhibitor
September 17, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 1b/2 NORSE (NCT03473743) study evaluating BALVERSA® (erdafitinib) in combination with cetrelimab, an anti-programmed cell death protein 1 (PD-1) monoclonal antibody, compared to BALVERSA® monotherapy in patients with locally advanced or metastatic urothelial carcinoma (mUC) with fibroblast growth factor receptor (FGFR)3 or FGFR2 genetic alterations who are ineligible for cisplatin, a current standard of care treatment for mUC. The results were highlighted in an oral present...
Source: Johnson and Johnson - September 17, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Mayo Clinic Q and A: Constipation in children
DEAR MAYO CLINIC: My 10-year-old daughter spends hours in the bathroom daily. Every time I inquire, she tells me she is constipated. We do not eat out a lot, and we incorporate fruits or vegetables at each meal. She also drinks water most of the day. Is constipation normal at this age, and what can I do to help her? ANSWER: Constipation can cause issues with bowel movements in as many as 30% of children. It's a common… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 17, 2021 Category: Databases & Libraries Source Type: news

Cochrane Library Editorial - Anticholinergic drugs and dementia: time for transparency in the face of uncertainty
 Would you choose a treatment option that might increase your risk of developing dementia?Anticholinergic drugs (which contract smooth muscle, reduce heart rate, dilate blood vessels, and increase bodily secretions)  are commonly used in clinical practice for the management of many conditions affecting older adults - for example for urinary incontinence and for treating depression. As a consequence, the cumulative anticholinergic exposure for older people taking medications for multiple health conditions can b e underestimated. The sum of this exposure is called anticholinergic burden (ACB). Some anticholinergic ...
Source: Cochrane News and Events - September 8, 2021 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress
September 8, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than ten data presentations from its lung cancer, bladder cancer and prostate cancer portfolio and pipeline will be featured during the European Society for Medical Oncology (ESMO) Annual Congress 2021 virtual meeting, September 16–21. Further details about these data and the science Janssen is advancing will be made available throughout ESMO via the Janssen Oncology Virtual Newsroom.“With a diverse oncology portfolio and pipeline spanning bladder cancer, lung cancer and prostate can...
Source: Johnson and Johnson - September 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Association between abuse and neglect with functional constipation and irritable bowel syndrome in adolescents - Thomaz de Almeida CN, Tahan S, Areco KN, Morais MB.
OBJECTIVES: To evaluate the association between violence exposure, abuse, and neglect victimization with functional constipation and irritable bowel syndrome in adolescents. METHODS: Observational cross-sectional case-control study conducted with a... (Source: SafetyLit)
Source: SafetyLit - September 6, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

How does Lichen Sclerosus et Atrophicus Present?
Discussion Lichen sclerosus et atrophicus (LSA) is a chronic inflammatory disease with a strong autoimmune association. It can occur with other autoimmune diseases. Its specific cause is unknown. It affects females and males of all ages, but especially females 40-60 years. In the pediatric population it affects prepubertal females most often. Treatment includes steroid medications or anti-inflammatory medications. Other treatments may be offered including phototherapy, and much less commonly systemic steroids or immunosuppressive therapy. Circumcision may also be an option for some males. Childhood LSA generally improves b...
Source: PediatricEducation.org - September 6, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Constipation diet: The ONE surprising fruit that could treat constipation
CONSTIPATION affects nearly 30 percent of the population, but what if ONE fruit could treat it? (Source: Daily Express - Health)
Source: Daily Express - Health - August 30, 2021 Category: Consumer Health News Source Type: news

Science Saturday: How disease, diet, and genomics interact with gut virome
Mayo Clinic researchers published a comprehensive analysis of the gut virome in  Gastroenterology, showing how disease, diet and genomics interact with the gut virome in irritable bowel syndrome. This common disorder affects the intestine and manifests as abdominal pain associated with constipation, diarrhea or both. The gut virome is one component of the microbiome (bacteria , fungi, viruses). It includes viruses that specifically attack bacteria (bacteriophages/phages) or those affecting humans (eukaryotic viruses. e.g., norovirus). Hence the gut virome… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 21, 2021 Category: Databases & Libraries Source Type: news

Janssen Presents Phase 1 Results for RYBREVANTTM (amivantamab-vmjw) in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations
August 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced preliminary data from the Phase 1 CHRYSALIS study evaluating RYBREVANTTM (amivantamab-vmjw) for the treatment of patients with non-small cell lung cancer (NSCLC) with mesenchymal-epithelial transition (MET) exon 14 skipping (METex14) mutations. The initial data showed anti-tumor activity in patients with METex14 mutations and a safety profile consistent with reported experience at the approved CHRYSALIS Phase 2 dose (RYBREVANTTM 1050 mg [
Source: Johnson and Johnson - August 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Mayo Clinic Q and A: Increasing fiber intake for constipation relief
DEAR MAYO CLINIC: I experience constipation almost weekly, and eating bran flakes every day isn ’t helping. Are fiber supplements safe to use regularly and long term? Is there anything else I can do? I’m a 53-year-old woman and otherwise in excellent health. ANSWER: When consumed at recommended levels, dietary fiber is widely recognized to have health benefits, including relief of constipation. Adult women 50 and younger should consume at least 25 grams of fiber a day. Women… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 10, 2021 Category: Databases & Libraries Source Type: news

Stomach bloating: Want to beat the bloat? Five reasons you should take digestive enzymes
LOOKING for how to beat the bloat? Taking digestive enzymes could be the answer, according to nutritionist Rob Thorp. And there are other reasons why you should be taking them too - from boosting your energy levels to curbing constipation. (Source: Daily Express - Health)
Source: Daily Express - Health - August 8, 2021 Category: Consumer Health News Source Type: news

Data for Roche ’s Evrysdi® (risdiplam) published in New England Journal of Medicine shows significant improvement in survival and motor milestones in babies with Type 1 spinal muscular atrophy (SMA)
Basel, 29 July 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the New England Journal of Medicine (NEJM) has published data from FIREFISH Part 2, a pivotal global study evaluating the efficacy and safety of Evrysdi® (risdiplam) in babies aged 1-7 months old with symptomatic Type 1 spinal muscular atr ophy (SMA). The study met its primary endpoint with 29% of infants (12/41) sitting without support for at least five seconds* by month 12, a milestone not seen in the natural course of the disease. Safety for Evrysdi in the FIREFISH Part 2 study was consistent with its known safety profile.“With...
Source: Roche Media News - July 29, 2021 Category: Pharmaceuticals Source Type: news

Data for Roche ’s Evrysdi® (risdiplam) published in New England Journal of Medicine shows significant improvement in survival and motor milestones in babies with Type 1 spinal muscular atrophy (SMA)
Basel, 29 July 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the New England Journal of Medicine (NEJM) has published data from FIREFISH Part 2, a pivotal global study evaluating the efficacy and safety of Evrysdi® (risdiplam) in babies aged 1-7 months old with symptomatic Type 1 spinal muscular atr ophy (SMA). The study met its primary endpoint with 29% of infants (12/41) sitting without support for at least five seconds* by month 12, a milestone not seen in the natural course of the disease. Safety for Evrysdi in the FIREFISH Part 2 study was consistent with its known safety profile.“With...
Source: Roche Investor Update - July 29, 2021 Category: Pharmaceuticals Source Type: news

High-Tech Exoskeletons Improve Bowel Function in People With Spinal Cord Injury
FRIDAY, July 23, 2021 -- Digestive issues are common after spinal cord injury and can lead to chronic constipation and incontinence. But robotic exoskeleton-assisted walking can improve matters in people with such injuries, researchers say. In an... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 23, 2021 Category: General Medicine Source Type: news

How to treat constipation: The 11 foods to AVOID when constipated
CONSTIPATION isn't usually anything to worry about and is normally easily fixed, starting with changes to your diet. Here are 11 foods to avoid when constipated. (Source: Daily Express - Health)
Source: Daily Express - Health - July 21, 2021 Category: Consumer Health News Source Type: news

Enulose (Lactulose Solution) - updated on RxList
Enulose (lactulose) Solution is used to treat chronic constipation. Learn side effects, dosage, drug interactions, warnings, patient labeling, reviews, and more. (Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 21, 2021 Category: Drugs & Pharmacology Source Type: news

Constipation, flatulence, burping, and more: Is something wrong?
Yale doctors share some of the GI issues they frequently treat, suggest steps you can take at home — and explain when you should seek advice from a physician. (Source: Yale Science and Health News)
Source: Yale Science and Health News - July 15, 2021 Category: Universities & Medical Training Source Type: news

What causes constipation? The two drinks you should AVOID
CONSTIPATION is a common problem where you can't manage to go to the toilet enough. But what causes it and are there certain foods and drinks to avoid? (Source: Daily Express - Health)
Source: Daily Express - Health - July 15, 2021 Category: Consumer Health News Source Type: news

A Closer Look at the Colon Condition That Hospitalized the Pope
Francis suffered a disorder that is relatively common and treatable, and doctors expect him to make a full recovery. (Source: NYT Health)
Source: NYT Health - July 5, 2021 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Colon Digestive Tract Surgery and Surgeons Antibiotics Constipation Fiber (Dietary) Diverticulosis Age, Chronological Roman Catholic Church Gemelli Francis Source Type: news

How to deal with common digestive problems
Stomach woes become more common with age. Lifestyle changes can make a big difference with heartburn, bloating, constipation, gas and lactose intolerance. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - June 28, 2021 Category: Consumer Health News Authors: Sally Wadyka Source Type: news

Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX ® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant Ineligible
Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced overall survival (OS) results from the Phase 3 MAIA (NCT02252172) study showing the addition of DARZALEX® (daratumumab) to lenalidomide and dexamethasone (D-Rd) resulted in a statistically significant survival benefit over lenalidomide and dexamethasone (Rd) alone in patients with newly diagnosed multiple myeloma (NDMM) who were ineligible for autologous stem cell transplant (ASCT) and were treated to progression.[1] These data were featured in the European Hematology Association (EHA) 2021 Virtual Press Briefin...
Source: Johnson and Johnson - June 12, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
June 1, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. Janssen presentations will include new data and updates for both approved and investigational therapeutics that are being studied for the treatment of various solid tumors and blood cancers. Immediately following ASCO, additional data will be featured during the European Hematology Association (EHA) Virtual Congress, June 9-17. A ...
Source: Johnson and Johnson - June 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Is Constipation Normal in the First Trimester
Is It Normal to Be Constipated in the First Trimester? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 27, 2021 Category: General Medicine Source Type: news

Updated Data Demonstrate Significant Improvement in Hematologic Complete Response with DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
RARITAN, N.J., May 26, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated results from the Phase 3 ANDROMEDA study, which evaluated DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for the treatment of patients with newly diagnosed light chain (AL) amyloidosis, a rare blood cell disorder associated with the deterioration of vital organs, most notably the heart, kidneys and liver.[1] Longer-term results from a median follow-up of 20.3 months showed rates of hematologic complete response (hemCR) remained significantly higher in patients treated with DARZALEX FASPRO®...
Source: Johnson and Johnson - May 26, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

RYBREVANTTM (amivantamab-vmjw) Receives FDA Approval as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
May 21, 2021 (HORSHAM, P.A.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has granted the accelerated approval of RYBREVANTTM (amivantamab-vmjw) for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy.[1] RYBREVANTTM is the first fully-human, bispecific antibody approved for the treatment of patients with NSCLC t...
Source: Johnson and Johnson - May 21, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Emergency medicine: 9 Healing herbs to grow at home before SHTF
(Natural News) Healing herbs are every prepper’s go-to medicines when SHTF. These natural medicines have been used for centuries to treat a variety of ailments, such as wounds, fever and constipation. On top of that, many medicinal herbs are quite easy to grow and require very little maintenance. Watering them every now and then and ensuring that they... (Source: NaturalNews.com)
Source: NaturalNews.com - May 6, 2021 Category: Consumer Health News Source Type: news

Healing Words: The Opioid-Induced Constipation Crisis
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - May 1, 2021 Category: Emergency Medicine Tags: Healing Words Source Type: news

Three More Things We Do for No Reason in Pediatrics Three More Things We Do for No Reason in Pediatrics
The Cribsiders share their favorite easy-to-implement pearls on CAP, cellulitis, and constipation in kids.The Cribsiders (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 30, 2021 Category: Consumer Health News Tags: Pediatrics Commentary Source Type: news

Get Moving on Constipation
Dear Dr. Jeff: Recently our facility had a patient who complained of abdominal pain and vomiting. She was sent to the emergency department where she received a Fleet enema and was returned with a diagnosis of “fecal impaction.” The family complained to surveyors who cited us for a Level G deficiency and imposed a $5,000 fine. The facility leadership has focused on the decision to transfer the resident to the hospital as the problem, but it seems to me that more needs to be fixed. Any suggestions? (Source: Caring for the Ages)
Source: Caring for the Ages - April 28, 2021 Category: Health Management Authors: Jeffrey Nichols Tags: Dear Dr. Jeff Source Type: news

Dramatic Rise in Use of Drugs for Opioid-Induced Constipation Dramatic Rise in Use of Drugs for Opioid-Induced Constipation
Use of these drugs soared during a period of 4 years, propelled by a Super Bowl advertisement, prompting calls for defining appropriate use of these agents.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 27, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Diabetes type 2 symptoms: Constipation may indicate nerve damage
DIABETES may continue to disrupt your internal processes, with symptoms so slight, you don't realise the significant damage being done inside. Struggling to release bowel movements might be more sinister than once thought. (Source: Daily Express - Health)
Source: Daily Express - Health - April 18, 2021 Category: Consumer Health News Source Type: news

Constipation treatment Vibrant raises $7.5 million led by Unorthodox Ventures
Sequoia Capital invests for fourth time as treatment continues third round of FDA trials YOKNEAM ILLIT, Israel, March 26, 2021 -- (Healthcare Sales & Marketing Network) -- Vibrant, a leading developer of gastrointestinal treatments, today announced the... Devices, Gastroenterology, Venture Capital Vibrant Ltd, vibrating capsule (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 26, 2021 Category: Pharmaceuticals Source Type: news

What Are Generalized Anxiety Disorder Treatment Components?
Discussion Generalized anxiety disorder (GAD) is “…excessive anxiety and worry about a number of events and activities coupled with at least one physical symptom, which may include fatigue, poor concentration, restlessness, irritability, muscle tension, and sleep difficulties.” Other ways it presents to the primary care office may be abdominal pain, headache or heart palpitations, dizziness, syncope, numbness, trembling, paresthesia, memory loss, or urinary frequency. It has an estimated prevalence of 15% and is the second most common anxiety disorder in children after social anxiety disorder. GAD can co...
Source: PediatricEducation.org - March 15, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

FDA qualifies C-Path's Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C)
(Critical Path Institute (C-Path)) C-Path Patient-Reported Outcome Consortium announces the qualification of the Diary for Irritable Bowel Syndrome Symptoms-Constipation by FDA. The DIBSS-C was developed by the PRO Consortium's Irritable Bowel Syndrome Working Group to support symptom-based efficacy endpoints in clinical trials for products intended to treat constipation-predominant IBS in adults. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 9, 2021 Category: International Medicine & Public Health Source Type: news

Splinting: What is it and is the TikTok constipation hack dangerous?
SPLINTING is not a new thing and according to TikTok users, it's an effective hack to solve constipation. But is splinting dangerous? (Source: Daily Express - Health)
Source: Daily Express - Health - March 4, 2021 Category: Consumer Health News Source Type: news

What Is the Difference Between Fecal Impaction and Constipation?
Title: What Is the Difference Between Fecal Impaction and Constipation?Category: Diseases and ConditionsCreated: 3/4/2021 12:00:00 AMLast Editorial Review: 3/4/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - March 4, 2021 Category: Nutrition Source Type: news

Antidepressants could be prescribed by GPs as the new weapon in the war on Irritable Bowel Syndrome
IBS affects nine million Britons, causing agonising pain, bloating, diarrhoea and constipation - with few effective treatments available. (Source: the Mail online | Health)
Source: the Mail online | Health - February 27, 2021 Category: Consumer Health News Source Type: news

Roche receives positive CHMP opinion for Evrysdi, the first and only at home spinal muscular atrophy (SMA) treatment with proven efficacy in adults, children and infants two months and older
Basel, 26 February 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Evrysdi ™ (risdiplam) for the treatment of 5q spinal muscular atrophy (SMA) in patients 2 months of age and older, with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies. SMA is a leading genetic cause of death in infants and 5q SMA is the most common form of the disease . SMA causes progressive muscle weakness and atrophy, and significant unmet need remains, particularly in adults ...
Source: Roche Media News - February 26, 2021 Category: Pharmaceuticals Source Type: news

Roche receives positive CHMP opinion for Evrysdi, the first and only at home spinal muscular atrophy (SMA) treatment with proven efficacy in adults, children and infants two months and older
Basel, 26 February 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Evrysdi ™ (risdiplam) for the treatment of 5q spinal muscular atrophy (SMA) in patients 2 months of age and older, with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies. SMA is a leading genetic cause of death in infants and 5q SMA is the most common form of the disease . SMA causes progressive muscle weakness and atrophy, and significant unmet need remains, particularly in adults ...
Source: Roche Investor Update - February 26, 2021 Category: Pharmaceuticals Source Type: news

What Can Constipation be a Sign Of?
Title: What Can Constipation be a Sign Of?Category: Diseases and ConditionsCreated: 2/24/2021 12:00:00 AMLast Editorial Review: 2/24/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - February 24, 2021 Category: Nutrition Source Type: news

Toxic Clostridioides (formerly Clostridium) difficile colitis: No longer a diarrhea associated infection, American journal of surgery 221(1): 240-242
Conclusion: CDI must be suspected in patients who rapidly develop abdominal distention, vague abdominal complaints or change in bowel function even in the absence of diarrhea, especially if coupled with multi-system organ failure. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 19, 2021 Category: Consumer Health News Source Type: news